ROCHE-WO20698 (CLEOPATRA)



A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Herceptin + docetaxel + pertuzumab versus Herceptin + docetaxel + placebo in previously untreated HER2-positive metastatic breast cancer
pertuzumab
WO20698 (CLEOPATRA)
NCT00567190
malignant neoplasm of breast
Phase 3
 
January 2014